← Leaderboards
Keith T Wilson
Vanderbilt University Medical Center
$21,094,933
Attributed
$22,812,637
Total exposure
24
Grants
20
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$28,004,381 · 22
VA$0 · 3
By mechanism
R01$13,155,484 · 4
P01$10,812,630 · 10
P30$2,582,747 · 2
R21$764,500 · 2
R41$400,000 · 1
R03$148,500 · 1
Top collaborators
- Douglas Morgan6 shared
- Pelayo Correa3 shared
- John A Rathmacher1 shared
Most similar at Vanderbilt University Medical Center
Same institution · by research overlap
- Richard M Peek$40,629,039
- Kristen Keon Ciombor$1,859,641
Others in their field
Top investigators on “Inflammation”
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
- Sharon L Hillier · Magee-Women'S Hospital Of Upmc$89,523,713
- David Heimbrook · Leidos Biomedical Research, Inc.$85,243,263
- Randall J Bateman · Washington University$64,707,456
- Peter Scott Heeger · Case Western Reserve University$56,547,884
Research focus
InflammationPolyaminesCarcinogenesisMalignant NeoplasmsResponsePathway InteractionsOrnithine DecarboxylaseStomachHelicobacter PyloriEpithelial CellsChronicMalignant Stomach NeoplasmMolecularReportingEnzymesInfectionCancer RiskImmune ResponseLeadGastritisDna DamageMetabolismExhibitsHelicobacter Infections
Grant awards (100)
Pilot and Feasibility Program$322,180
P30 · FY2025 · DK · contact PI
Polyamines and Electrophiles in Gastric Cancer$283,836
P01 · FY2025 · CA · contact PI
"Dysregulated Polyamine Metabolism in H. pylori-associated Gastric Inflammation and Disease Progression"$0
I01 · FY2025 · VA · contact PI
BCCMA: Targeting Gut-Microbiome in Veterans Deployment Related Gastrointestinal and Liver Diseases: Dysbiosis, PTSD, and Epithelial and Immune Biology in Inflammatory Bowel Disease in Veterans$0
I01 · FY2025 · VA · contact PI
Spermidine as a New Therapy for Colitis and Chemopreventive for Colitis-associated Carcinogenesis$648,415
R01 · FY2024 · DK · contact PI
Polyamines and Electrophiles in Gastric Cancer$349,540
P01 · FY2024 · CA · contact PI
Pilot and Feasibility Program$322,180
P30 · FY2024 · DK · contact PI
Dysregulated Polyamine Metabolism in H. pylori-associated Gastric Inflammation and Disease Progression$0
I01 · FY2024 · VA · contact PI
BCCMA: Targeting Gut-Microbiome in Veterans Deployment Related Gastrointestinal and Liver Diseases: Dysbiosis, PTSD, and Epithelial and Immune Biology in Inflammatory Bowel Disease in Veterans$0
I01 · FY2024 · VA · contact PI
Spermidine as a New Therapy for Colitis and Chemopreventive for Colitis-associated Carcinogenesis$675,434
R01 · FY2023 · DK · contact PI
Pilot and Feasibility Program$322,180
P30 · FY2023 · DK · contact PI
Project 2: EGFR, ODC, and the Hypusome in H. pylori-induced Gastric Cancer$313,793
P01 · FY2023 · CA · contact PI
BCCMA: Targeting Gut-Microbiome in Veterans Deployment Related Gastrointestinal and Liver Diseases: Dysbiosis, PTSD, and Epithelial and Immune Biology in Inflammatory Bowel Disease in Veterans$0
I01 · FY2023 · VA · contact PI
Dysregulated Polyamine Metabolism in H. pylori-associated Gastric Inflammation and Disease Progression$0
I01 · FY2023 · VA · contact PI
Spermidine as a New Therapy for Colitis and Chemopreventive for Colitis-associated Carcinogenesis$675,434
R01 · FY2022 · DK · contact PI
Pilot and Feasibility Program$322,180
P30 · FY2022 · DK · contact PI
Project 2: EGFR, ODC, and the Hypusome in H. pylori-induced Gastric Cancer$266,643
P01 · FY2022 · CA · contact PI
Dysregulated Polyamine Metabolism in H. pylori-associated Gastric Inflammation and Disease Progression$0
I01 · FY2022 · VA · contact PI
Spermidine as a New Therapy for Colitis and Chemopreventive for Colitis-associated Carcinogenesis$675,425
R01 · FY2021 · DK · contact PI
Efficacy of an Electrophile Scavenger in the Prevention of Gastrointestinal Inflammatory Carcinogenesis$400,000
R41 · FY2021 · CA
Project 2: EGFR, ODC, and the Hypusome in H. pylori-induced Gastric Cancer$319,400
P01 · FY2021 · CA · contact PI
PILOT AND FEASIBILITY PROGRAM$292,862
P30 · FY2021 · DK · contact PI
Dysregulated Polyamine Metabolism in H. pylori-associated Gastric Inflammation and Disease Progression$0
I01 · FY2021 · VA · contact PI
Project 2: EGFR, ODC, and the Hypusome in H. pylori-induced Gastric Cancer$326,687
P01 · FY2020 · CA · contact PI
PILOT AND FEASIBILITY PROGRAM$234,731
P30 · FY2020 · DK · contact PI
The Macrophage Reverse Transsulfuration Pathway: A Novel Mediator of Helicobacter pylori Immunopathogenesis$212,500
R21 · FY2020 · AI · contact PI
Dysregulated Polyamine Metabolism in H. pylori-associated Gastric Inflammation and Disease Progression$0
I01 · FY2020 · VA · contact PI
Etiological Studies of Gastric Carcinoma$1,007,531
P01 · FY2019 · CA · contact PI
Project 2: EGFR, ODC, and the Hypusome in H. pylori-induced Gastric Cancer$328,691
P01 · FY2019 · CA · contact PI
The Macrophage Reverse Transsulfuration Pathway: A Novel Mediator of Helicobacter pylori Immunopathogenesis$255,000
R21 · FY2019 · AI · contact PI
PILOT AND FEASIBILITY PROGRAM$238,114
P30 · FY2019 · DK · contact PI
2019 Polyamines GRS/GRC$12,000
R13 · FY2019 · CA · contact PI
Arginine Availability and Metabolism in H. pylori-associated Gastric Inflammation and Disease Progression$0
I01 · FY2019 · VA · contact PI
Etiological Studies of Gastric Carcinoma$1,038,693
P01 · FY2018 · CA · contact PI
Targeted chemoprevention of gastric carcinogenesis in high risk populations$568,634
R01 · FY2018 · CA · contact PI
PILOT AND FEASIBILITY PROGRAM$235,458
P30 · FY2018 · DK · contact PI
Core B - Administrative Core$96,243
P01 · FY2018 · CA · contact PI
Arginine Availability and Metabolism in H. pylori-associated Gastric Inflammation and Disease Progression$0
I01 · FY2018 · VA · contact PI
Etiological Studies of Gastric Carcinoma$1,038,693
P01 · FY2017 · CA · contact PI
Targeted chemoprevention of gastric carcinogenesis in high risk populations$711,577
R01 · FY2017 · CA · contact PI
Immunomodulatory effects of arginine supplementation in colitis and colon cancer$395,000
R01 · FY2017 · AT · contact PI
PILOT AND FEASIBILITY PROGRAM$292,862
P30 · FY2017 · DK · contact PI
EGFR Activation and Polyamines in H.Pylori-Induced Gastric Cancer$282,317
P01 · FY2017 · CA · contact PI
Project 3 - Molecular Signatures of Gastric Carcinogenesis in the Host Response to H. pylori$238,800
P01 · FY2017 · CA · contact PI
Core B - Administrative Core$74,116
P01 · FY2017 · CA · contact PI
Arginine Availability and Metabolism in H. pylori-associated Gastric Inflammation and Disease Progression$0
I01 · FY2017 · VA · contact PI
Etiological Studies of Gastric Carcinoma$1,043,984
P01 · FY2016 · CA · contact PI
Targeted chemoprevention of gastric carcinogenesis in high risk populations$574,462
R01 · FY2016 · CA · contact PI
Immunomodulatory effects of arginine supplementation in colitis and colon cancer$395,000
R01 · FY2016 · AT · contact PI
Project 3 - Molecular Signatures of Gastric Carcinogenesis in the Host Response to H. pylori$240,016
P01 · FY2016 · CA · contact PI
EGFR Activation and Polyamines in H.Pylori-Induced Gastric Cancer$202,669
P01 · FY2016 · CA · contact PI
EGFR Activation and Polyamines in H.Pylori-Induced Gastric Cancer$78,205
P01 · FY2016 · CA · contact PI
Core B - Administrative Core$74,494
P01 · FY2016 · CA · contact PI
Arginine Availability and Metabolism in H. pylori-associated Gastric Inflammation and Disease Progression$0
I01 · FY2016 · VA · contact PI
Etiological Studies of Gastric Carcinoma$533,866
P01 · FY2015 · CA · contact PI
Etiological Studies of Gastric Carcinoma$528,977
P01 · FY2015 · CA · contact PI
Targeted chemoprevention of gastric carcinogenesis in high risk populations$528,509
R01 · FY2015 · CA · contact PI
EGFR Activation and Polyamines in H.Pylori-Induced Gastric Cancer$276,180
P01 · FY2015 · CA · contact PI
Project 3 - Molecular Signatures of Gastric Carcinogenesis in the Host Response to H. pylori$234,946
P01 · FY2015 · CA · contact PI
Immunomodulatory effects of arginine supplementation in colitis and colon cancer$218,330
R01 · FY2015 · AT · contact PI
Immunomodulatory effects of arginine supplementation in colitis and colon cancer$159,970
R01 · FY2015 · AT · contact PI
Project 3 - Molecular Signatures of Gastric Carcinogenesis in the Host Response to H. pylori$122,737
P01 · FY2015 · CA · contact PI
Core B - Administrative Core$76,149
P01 · FY2015 · CA · contact PI
Targeted chemoprevention of gastric carcinogenesis in high risk populations$45,993
R01 · FY2015 · CA · contact PI
Core B - Administrative Core$38,095
P01 · FY2015 · CA · contact PI
Arginine Availability and Metabolism in the Immune Evasion of H. pylori$0
I01 · FY2015 · VA · contact PI
Targeted chemoprevention of gastric carcinogenesis in high risk populations$606,233
R01 · FY2014 · CA · contact PI
Immunomodulatory effects of arginine supplementation in colitis and colon cancer$378,300
R01 · FY2014 · AT · contact PI
H. pylori induced DNA Damage and Immune Dysregulation$307,401
R01 · FY2014 · DK · contact PI
EGFR Activation and Polyamines in H.Pylori-Induced Gastric Cancer$280,150
P01 · FY2014 · CA · contact PI
H. pylori induced DNA Damage and Immune Dysregulation$32,101
R01 · FY2014 · DK · contact PI
Arginine Availability and Metabolism in the Immune Evasion of H. pylori$0
I01 · FY2014 · VA · contact PI
Immunomodulatory effects of arginine supplementation in colitis and colon cancer$370,500
R01 · FY2013 · AT · contact PI
H. pylori induced DNA Damage and Immune Dysregulation$327,425
R01 · FY2013 · DK · contact PI
H. Pylori Induced Oxidative Stress$213,321
P01 · FY2013 · CA · contact PI
Arginine Availability and Metabolism in the Immune Evasion of H. pylori$0
I01 · FY2013 · VA · contact PI
H. pylori induced DNA Damage and Immune Dysregulation$339,300
R01 · FY2012 · DK · contact PI
H. Pylori Induced Oxidative Stress$223,137
P01 · FY2012 · CA · contact PI
Arginine Availability and Metabolism in the Immune Evasion of H. pylori$0
I01 · FY2012 · VA · contact PI
H. pylori induced DNA Damage and Immune Dysregulation$390,000
R01 · FY2011 · DK · contact PI
Immunomodulatory effects of arginine supplementation in colitis and colon cancer$372,874
R01 · FY2011 · AT · contact PI
H. Pylori Induced Oxidative Stress$222,745
P01 · FY2011 · CA · contact PI
Immunomodulatory effects of arginine supplementation in colitis and colon cancer$376,736
R01 · FY2010 · AT · contact PI
H. Pylori Induced Oxidative Stress$228,596
P01 · FY2010 · CA · contact PI
Immunomodulatory effects of arginine supplementation in colitis and colon cancer$620,311
R01 · FY2009 · AT · contact PI
Immunomodulatory effects of arginine supplementation in colitis and colon cancer$380,635
R01 · FY2009 · AT · contact PI
H pylori Induced DNA Damage and Immune Dysregulation$281,022
R01 · FY2009 · DK · contact PI
H. Pylori Induced Oxidative Stress$229,380
P01 · FY2009 · CA · contact PI
Immunomodulatory effects of arginine supplementation in colitis and colon cancer$380,726
R01 · FY2008 · AT · contact PI
H pylori Induced DNA Damage and Immune Dysregulation$282,122
R01 · FY2008 · DK · contact PI
H pylori Induced DNA Damage and Immune Dysregulation$288,973
R01 · FY2007 · DK · contact PI
H pylori Induced DNA Damage and Immune Dysregulation$298,078
R01 · FY2006 · DK · contact PI
H pylori Induced DNA Damage and Immune Dysregulation$302,580
R01 · FY2005 · DK
iNOS, COX-2, and Arginase in Murine Barrett's Esophagus$148,500
R21 · FY2003 · DK
iNOS, COX-2, and Arginase in Murine Barrett's Esophagus$148,500
R21 · FY2002 · DK
HPYLORI INDUCED DNA DAMAGE AND IMMUNE DYSREGULATION$278,012
R01 · FY2001 · DK
REGULATION OF COLITIS BY CYCLOOXYGENASE-2$74,250
R03 · FY2001 · DK
HPYLORI INDUCED DNA DAMAGE AND IMMUNE DYSREGULATION$269,972
R01 · FY2000 · DK
EPITHELIAL NITRIC OXIDE IN INTESTINAL INFLAMMATION$128,520
K08 · FY2000 · DK
REGULATION OF COLITIS BY CYCLOOXYGENASE-2$74,250
R03 · FY2000 · DK